Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed in Geriatric Individuals
25 avril 2026 mis à jour par: Gulfidan Tokgoz, Istanbul University - Cerrahpasa
Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed Threshold Values in Geriatric Individuals
The aim of this study is to examine the determining role of walking speed on physical performance parameters in individuals aged 65 and over.
The study aims to compare flexibility, lower extremity muscle strength (5-count sit-stand test), static balance (single-leg balance), upper extremity muscle strength (hand grip), dynamic balance (FUT), functional mobility (TUG), and stair climbing/climbing skills in individuals with walking speeds of 0.4-0.8
m/s (limited community mobility) and above 0.8 m/s (independent community mobility).
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Intervention / Traitement
Description détaillée
Although the relationships between walking speed and individual physical parameters have been studied in the geriatric literature, comprehensive analyses comparing multidimensional parameters such as flexibility, static-dynamic balance, hand grip strength, and stair activity performance in groups separated according to walking speed threshold values (0.4-0.8 m/s and >0.8 m/s) are needed.
This study aims to identify which physical components show the most significant deficits when walking speed decreases, thereby providing a scientific basis for clinical assessment processes and personalized preventive rehabilitation programs.
Type d'étude
Observationnel
Inscription (Estimé)
76
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Numéro de téléphone: 0552 022 76 32
- E-mail: gulfidan.tokgoz@gmail.com
Lieux d'étude
-
-
-
Balıkesir, Turquie (Türkiye)
- Balıkesir University
-
Contact:
- GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Numéro de téléphone: 0552 022 76 32
- E-mail: gulfidan.tokgoz@gmail.com
-
Sous-enquêteur:
- Bilal Katipoğlu, Assoc. Prof. Dr.
-
Contact:
- Nilay ARMAN, Assoc. Prof. Dr.
- Numéro de téléphone: +905534558707
-
Sous-enquêteur:
- Saime Nilay Arman, Assoc. Prof. Dr.
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte plus âgé
Accepte les volontaires sains
Oui
Méthode d'échantillonnage
Échantillon de probabilité
Population étudiée
Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
La description
Inclusion Criteria:
- Being 65 years of age or older
- Being able to perform walking functions
- Having sufficient mobility to perform the physical performance tests included in the research, such as 5 sit-stand tests, TUG (Trip and Go) tests, and stair climbing/descending tests. • Having a walking speed of at least 0.4 m/s or more as a result of the 4 Meter Walking Test (having limited or independent mobility within the community).
- Voluntarily agreeing to participate in the study and providing informed consent.
Exclusion Criteria:
- Having a history of advanced cognitive impairment or diagnosed dementia that would impair the ability to understand and follow test instructions.
- Those diagnosed with moderate or severe cognitive impairment (MMSE < 24 and/or MoCA < 21)
- Having a walking speed below 0.4 m/s on the 4-Meter Walk Test (individuals who are wheelchair-bound or bedridden).
- Advanced Parkinson's disease, active stroke sequelae, lower extremity fracture within the last 6 months, or a history of acute orthopedic surgery that primarily affects motor performance and balance.
- Those with severe hearing or vision loss
- Individuals experiencing significant difficulty communicating
- Participants who did not sign the voluntary consent form
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Geriartric Indivıduals
Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
|
Assessments will be conducted after obtaining voluntary consent from the participants.
The physical performance tests to be applied within the scope of the research will be carried out by the research team within the framework of internationally accepted standard protocols whose validity and reliability have been proven in the geriatric population.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
4-Meter Walk Test (Walking Speed Measurement)
Délai: 1 week
|
Walking speed will be assessed using the 4-Meter Walk Test, a key indicator of functional mobility in geriatric individuals.
Participants will be asked to walk a 4-meter test area in the center at their "natural and comfortable walking speed," using 1-meter "acceleration" zones at the beginning and 1-meter "deceleration" zones at the end of a 6-meter flat course.
The measurement will be recorded with a stopwatch the moment the participant's foot crosses the 4-meter marked area, and the result will be calculated in m/s (Studenski et al., 2011).
|
1 week
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Time Sit-Stand Test (5STS):
Délai: 1 week
|
To assess lower extremity muscle strength and balance, participants will be asked to stand up and sit down as quickly as possible, five times consecutively, from a standard chair 43-45 cm high, with their arms crossed over their chest.
The timer will start with the "start" command and end when the fifth sitting is completed (Bohannon, 2006).
|
1 week
|
|
Timed Up and Go (TUG):
Délai: 1 week
|
To measure functional mobility, the participant will get up from the chair, walk a distance of 3 meters, return, and sit back down in the chair.
This time will be recorded in seconds using a stopwatch (Podsiadlo & Richardson, 1991).
|
1 week
|
|
Functional Reach Test (FUT/FRT)
Délai: 1 week
|
To measure static balance and stability limits, the maximum distance the participant can reach without losing balance and without taking a step, while standing next to a wall with the shoulder flexed at 90 degrees, will be measured (Duncan et al., 1990).
|
1 week
|
|
Single Leg Balance Test (Right and Left):
Délai: 1 week
|
Participants' static balance will be determined by recording the "time they can stand on one leg" (maximum 60 seconds) with their eyes open and hands on their hips, on both their dominant and non-dominant legs (Springer et al., 2007).
|
1 week
|
|
Flexibility (Sit-and-Reach Test):
Délai: 1 week
|
To measure hamstring and lower back flexibility, the participant will sit in a long, straight position, reaching forward without bending their knees.
The distance reached by their fingertips will be recorded on a "sit-and-reach bench" (Wells & Dillon, 1952).
|
1 week
|
|
Stair Climbing Test
Délai: 1 week
|
To assess high-level mobility, participants will be recorded in seconds for safely and as quickly as possible ascending and descending a staircase of standard step height [a specified number of steps, e.g., 10 steps] (Nightingale et al., 2003).
|
1 week
|
|
Strength Measurement (Hand Grip Strength):
Délai: 1 week
|
Upper extremity muscle strength will be measured using a digital hand dynamometer according to the ASHT (American Society of Hand Therapists) protocol.
Participants will be asked to grip with maximum force while sitting upright, with shoulder adduction and elbow 90 degrees flexed.
Three repetitions will be performed for each hand, and the average of these measurements in kilograms (kg) will be included in the analysis (Roberts et al., 2011; Cruz-Jentoft et al., 2019).
|
1 week
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009 Dec;13(10):881-9. doi: 10.1007/s12603-009-0246-z.
- Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015 Apr;23(2):314-22. doi: 10.1123/japa.2013-0236. Epub 2014 May 2.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
1 mai 2026
Achèvement primaire (Estimé)
15 mai 2026
Achèvement de l'étude (Estimé)
30 août 2026
Dates d'inscription aux études
Première soumission
25 avril 2026
Première soumission répondant aux critères de contrôle qualité
25 avril 2026
Première publication (Réel)
1 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
1 mai 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
25 avril 2026
Dernière vérification
1 avril 2026
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 2026/46
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .